Search form

 

Press Releases


Please select a year to review:
           

2014 | 2013 | 2012 | 2011 | 2010 | 2008 | 2007 | 2006 | 2005 | 2004

2006

December 12, 2006
Axcan Pharma Projects Solid Fiscal 2007 During Analyst and Investor Presentation

December 08, 2006
Axcan Pharma to Participate in the Gastroenterology Panel at the 2006 RBC Capital Markets Healthcare Conference

December 07, 2006
Axcan Pharma to Ring the NASDAQ Stock Market Closing Bell in New York on December 12, 2006

December 06, 2006
Axcan Pharma to Host Analyst and Investor Presentation in New York on December 12, 2006

November 30, 2006
Axcan Pharma Closes Fiscal 2006 with Record Annual Revenue of $292.3 Million, a 16.3% Increase Over Last Year

November 29, 2006
Axcan Pharma to Present at the BMO Capital Markets Focus on Healthcare Conference

November 21, 2006
Axcan Announces Conference Call and Webcast for Fourth Quarter and Fiscal 2006 Results

November 10, 2006
Axcan to Present at the Credit Suisse Healthcare Conference in Phoenix, Arizona

October 31, 2006
Axcan to Present at the CIBC World Markets 17th Annual Healthcare Conference

September 29, 2006
Axcan Receives FDA Approval Letter for PYLERA'TM' (Formerly Known as HELIZIDE), an Innovative 3-in-1 Capsule Triple Therapy for the Eradication of Helicobacter Pylori

September 27, 2006
Axcan to Present at the CIBC World Markets 5th Annual Institutional Investor Conference

September 26, 2006
Axcan and AGI Therapeutics Sign Exclusive License and Co-Development Agreement for the Next-Generation Therapy for GERD and the Control of Nocturnal Acid Breakthrough

September 22, 2006
Axcan to Present at the UBS Global Life Sciences Conference

September 20, 2006
Axcan Announces Results of the ITAX North American Phase III Clinical Study in Functional Dyspepsia

September 18, 2006
Axcan to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference in London, UK

August 30, 2006
Axcan to Present at the Thomas Weisel Partners Healthcare Conference

August 10, 2006
Axcan Announces Strong Third Quarter 2006 Revenue of $76.7 Million and Diluted Income Per Share of $0.26, Revenue Guidance for Fiscal 2006 Increased

August 01, 2006
Axcan Announces Conference Call and Webcast for Third Quarter of Fiscal 2006 Results

June 29, 2006
Axcan Pharma to be Included in the New NASDAQ Global Select Market(SM)

June 28, 2006
Post-Hoc Analyses of Phase II and International Phase III ITAX Trial Data Provide Insight to Axcan

June 15, 2006
Axcan Pharma to Present at Orion Securities' 11th Annual Healthcare Conference

May 10, 2006
Axcan Pharma appoints new Senior Vice President and Chief Scientific Officer

May 04, 2006
Axcan announces record revenue of $72.8 million for the second quarter of fiscal 2006

April 26, 2006
Axcan Pharma's President and CEO to provide Keynote Luncheon Speech at AMBAQ's Annual MBA Conference April 27, 2006

April 24, 2006
Axcan announces conference call and web cast for second quarter of fiscal 2006 results

April 19, 2006
Axcan Pharma to present at the Scotia Capital Pharmaceutical and Biotechnology Conference

April 18, 2006
Axcan Pharma to present at the UBS Global Specialty Pharmaceuticals Conference

March 29, 2006
Axcan submits FDA amendment to its new drug application for HELIZIDE

March 28, 2006
Axcan Pharma to present at CIBC World Markets Biotechnology and Specialty Pharmaceuticals Conference

February 22, 2006
Axcan announces outcome of ITAX International Phase III clinical trial

February 20, 2006
Axcan Pharma to hold Annual and Special Meeting of Shareholders February 22, 2006

February 13, 2006
Axcan announces conference call on statistical approach for Phase III trials of ITAX

February 09, 2006
Axcan announces record revenue of $70.6 million for the first quarter of fiscal 2006

February 08, 2006
Axcan Pharma to present at CIBC's Institutional Investor Conference

February 02, 2006
Axcan announces conference call and web cast for first quarter of fiscal 2006 results

January 31, 2006
Axcan Pharma to present at Merrill Lynch Global Healthcare Conference

January 20, 2006
Axcan Appoints Steve Gannon Senior Vice President and Chief Financial Officer

January 04, 2006
Axcan Pharma to present at JP Morgan's Healthcare Conference